切换至 "中华医学电子期刊资源库"

中华卫生应急电子杂志 ›› 2022, Vol. 08 ›› Issue (01) : 1 -5. doi: 10.3877/cma.j.issn.2095-9133.2022.01.001

所属专题: 指南共识

专家共识

西维来司他钠临床应用专家共识(2022)
中国研究型医院学会危重医学专业委员会, 中国医药教育协会重症医学专业委员会   
  • 收稿日期:2021-12-03 出版日期:2022-02-18
  • 基金资助:
    国家自然科学基金联合基金项目(U2004110); 国家自然科学基金面上项目(82172129); 中华国际医学交流基金会中青年医学研究专项基金(Z-2018-35); 中华国际医学交流基金会整合思维研究基金(Z-2016-23-2001)

Chinese experts’ consensus on clinical application of Sivelestat Sodium

Chinese Research Hospital Association of Critical Care Medicine, China Medical Education Association of Critical Care Medicine   

  • Received:2021-12-03 Published:2022-02-18
引用本文:

中国研究型医院学会危重医学专业委员会, 中国医药教育协会重症医学专业委员会. 西维来司他钠临床应用专家共识(2022)[J]. 中华卫生应急电子杂志, 2022, 08(01): 1-5.

Chinese Research Hospital Association of Critical Care Medicine, China Medical Education Association of Critical Care Medicine. Chinese experts’ consensus on clinical application of Sivelestat Sodium[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2022, 08(01): 1-5.

2020年新型冠状病毒肺炎(COVID-19)流行期间,西维来司他钠在我国快速上市治疗急性呼吸窘迫综合征(ARDS),但目前尚缺乏统一的临床用药指南和规范。为规范西维来司他钠在临床中的合理应用,中国研究型医院学会危重医学专业委员会、中国医药教育协会重症医学专业委员会组织国内众多重症医学、急诊医学、呼吸病学、临床药学等相关领域专家,对国内外相关文献进行分析、讨论、总结,共拟出5条建议,并经74名专家投票后制定本专家共识。

Sivelestat Sodium is a new drug rapidly marketed in China to treat acute respiratory distress syndrome (ARDS) during the Corona Virus Disease 19 (COVID-19) pandemic in 2020. However, there is a lack of unified clinical medication guidelines and standards. To standardize the rational application of Sivelestat sodium in clinical practice, the professional committee of the Chinese Research Hospital Association of Critical Care Medicine, and China Medical Education Association of Critical Care Medicine organized many domestic experts in critical medicine, emergency medicine, respiratory disease, clinical pharmacology and other related fields to analyze, discuss and summarize the relevant literature at home and abroad, and worked out five suggestions, and this consensus was formulated after 74 experts voted.

1
Aikawa N,,Ishizaka A,,Hirasawa H,et al.Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor,sivelestat,for the treatment of acute lung injury associated with systemic inflammatory response syndrome;a phase IV study[J].Pulm Pharmacol Ther201124(5):549-554.
2
Aikawa N,,Fujishima S,,Kobayashi M,et al.Cost-minimisation analysis of sivelestat for acute lung injury associated with systemic inflammatory response syndrome[J].Pharmacoeconomics200523(2):169-181.
3
Kawabata K,,Hagio T,,Matsuoka S.The role of neutrophil elastase in acute lung injury[J].Eur J Pharmacol2002451(1):1-10.
4
Kawabata K,,Suzuki M,,Sugitani M,et al.ONO-5046,a novel inhibitor of human neutrophil elastase[J].Biochem Biophys Res Commun1991177(2):814-820.
5
Domon H,,Nagai K,,Maekawa T,et al.Neutrophil elastase subverts the immune response by cleaving toll-like receptors and cytokines in pneumococcal pneumonia[J].Front Immunol20189(1):732-745.
6
Yanagihara K,,Fukuda Y,,Seki M,et al.Effects of specific neutrophil elastase inhibitor,sivelestat sodium hydrate,in murine model of severe pneumococcal pneumonia[J].Exp Lung Res200733(2):71-80.
7
王后红,李超,王哲芳,等.西维来司钠对急性坏死性胰腺炎肺损伤保护作用及其机制研究[J].中华急诊医学杂志201625(1):63-66.
8
Hagiwara S,,Iwasaka H,,Togo K,et al.A neutrophil elastase inhibitor,sivelestat,reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1[J].Inflammation200831(4):227-234.
9
Miyoshi S,,Ito R,,Katayama H,et al.Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients[J].Drug Des Devel Ther20148(13):1211-1219.
10
Aikawa N,,Fujishima S,,Kobayashi M,et al.Cost-minimisation analysis of sivelestat for acute lung injury associated with systemic inflammatory response syndrome[J].Pharmacoeconomics200523(2):169-181.
11
Kido T,,Muramatsu K,,Yatera K,et al.Efficacy of early sivelestat administration on acute lung injury and acute respiratory distress syndrome[J].Respirology201722(4):708-713.
12
Nakamura S,,Yanagihara K,,Izumikawa K,et al.Efficacy of sivelestat for acute lung injury due to severe bacterial pneumonia with systemic inflammatory response syndrome[J].Nihon Kokyuki Gakkai Zasshi200846(10):793-797.
13
Sahebnasagh A,,Saghafi F,,Safdari M,et al.Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/ acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19[J].J Clin Pharm Ther2020, 45(6):1515-1519.
14
Tsuboko Y,,Takeda S,,Mii S,et al.Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis[J].Drug Des Devel Ther20126(25):273-284.
15
Hayakawa M,,Katabami K,,Wada T,et al.Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients[J].Shock201033(1):14-18.
16
Hudson LD,,Milberg JA,,Anardi D,et al.Clinical risks for development of the acute respiratory distress syndrome[J].Am J Respir Crit Care Med1995151(21):293-301.
17
Tamakuma S,,Ogawa M,,Aikawa N,et al.Relationship between neutrophil elastase and acute lung injury in humans[J].Pulm Pharmacol Ther200417(5):271-279.
18
Wang ZQ,,Chen LQ,,Yuan Y,et al.Effects of neutrophil elastase inhibitor in patients undergoing esophagectomy:a systematic review and meta-analysis[J].World J Gastroenterol201521(12):3720-3730.
19
Inoue N,,Oka N,,Kitamura T,et al.Neutrophil elastase inhibitor sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass[J].Int Heart J201354(3):149-153.
20
Kohira S,,Oka N,,Inoue N,et al.Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass:a prospective randomized study[J].Artif Organs201337(12):1027-1033.
21
Toyama S,,Hatori F,,Shimizu A,et al.A neutrophil elastase inhibitor,sivelestat,improved respiratory and cardiac function in pediatric cardiovascular surgery with cardiopulmonary bypass[J].J Anesth200822(4):341-346.
22
Niino T,,Hata M,,Sezai A,et al.Efficacy of neutrophil elastase inhibitor on type A acute aortic dissection[J].Thorac Cardiovasc Surg201058(3):164-168.
23
Morimoto N,,Morimoto K,,Morimoto Y,et al.Sivelestat attenuates postoperative pulmonary dysfunction after total arch replacement under deep hypothermia[J].Eur J Cardiothorac Surg200834(4):798-804.
24
Novovic S,,Andersen AM,,Nord M,et al.Activity of neutrophil elastase reflects the progression of acute pancreatitis[J].Scand J Clin Lab Invest201373(6):485-493.
25
Bilyy R,,Fedorov V,,Vovk V,et al.Neutrophil extracellular traps form a barrier between necrotic and viable areas in acute abdominal inflammation[J].Front Immunol2016(7):424.
26
宁书蔚,董志扬.注射用西维来司他钠治疗急性胰腺炎引发的全身炎症反应综合征及急性肺损伤[J].肝胆胰外科杂志202133(10):631-634.
27
Hilscher MB,,Sehrawat T,,Arab JP,et al.Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils,generate sinusoidal microthombi,and promote portal hypertension[J].Gastroenterology2019157(1):193-209.
28
Raevens S,,Van Campenhout S,,Debacker PJ,et al.Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury[J].J Leukoc Biol2020107(2):341-355.
29
Araki Y,,Matsumiya M,,Matsuura T,et al.Sivelestat suppresses iNOS gene expression in proinflammatory cytokine-stimulated hepatocytes[J].Dig Dis Sci201156(6):1672-1681.
30
Tsujii S,,Okabayashi T,,Shiga M,et al.The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection[J].World J Surg201236(5):1122-1127.
31
Cao J,,Liu Q.Protective effects of sivelestat in a caerulein-induced rat acute pancreatitis model[J].Inflammation201336(6):1348-1356.
32
Zhou K.The effects of sivelestat sodium on severe acute pancreatitis complications[J].Farmacia201866(6):999-1007.
33
Mittendorf EA,,Alatrash G,,Qiao N,et al.Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response[J].Cancer Res201272(13):3153-3162.
34
Inoue H,,Kazawa T,,Sato Y,et al.In vivo observation of living cancer cells in the esophagus,stomach,and colon using catheter-type contact endoscope," Endo-Cytoscopy system" [J].Gastrointest Endosc Clin N Am200414(3):589-594.
35
Ho AS,,Chen CH,,Cheng CC,et al.Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers[J].Oncotarget20145(2):473-480.
36
Wada Y,,Yoshida K,,Hihara J,et al.Sivelestat,a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha[J].Cancer Sci200697(10):1037-1043.
37
Lerman I,,Garcia-Hernandez ML,,Rangel-Moreno J,et al.Infiltrating myeloid cells exert protumorigenic actions via neutrophil elastase[J].Mol Cancer Res201715(9):1138-1152.
38
Kam AYF,,Piryani SO,,McCall CM,et al.Targeting high mobility group box-1 (HMGB1) promotes cell death in myelodysplastic syndrome[J].Clin Cancer Res201925(13):4155-4167.
39
Polverino E,,RosalesMayor E,,Dale GE,et al.The role of neutrophil elastase inhibitors in lung diseases[J]. Chest2017152(2):249-262.
40
Yu X,,Zhao L,,Yu Z,et al.Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-kappaB in a rat model[J].Exp Ther Med201714(2):1531-1537.
41
Huo J,,Zhu XL,,Ma R,et al.GAPDH/Siah1 cascade is involved in traumatic spinal cord injury and could be attenuated by sivelestat sodium[J].Neuroscience2016(330):171-180.
42
bata R,,Yasukawa K,,Nagai K,et al.Sivelestat sodium hydrate treatment for refractory Kawasaki disease[J].Pediatr Int201961(5):438-443.
[1] 中华医学会器官移植学分会肺移植学组, 国家肺移植质控中心. 新型冠状病毒感染肺移植受者选择中国专家建议[J]. 中华移植杂志(电子版), 2023, 17(01): 13-16.
[2] 饶林静, 罗皓梨, 钟山. 不同时长PPV在体外循环心脏大血管术后并发ARDS中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 575-577.
[3] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[4] 罗婷, 张实. 5种生物标志物对ARDS预后的预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 471-475.
[5] 胡宗俊, 陈建国, 黄霞. ARDS机械通气继发肺栓塞危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 388-390.
[6] 张松涛, 李世金, 凌霄, 吴文辉. 胸部物理治疗联合布地奈德雾化对多发伤患者并发ARDS的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 373-375.
[7] 谭林, 蒲运刚, 朱顺, 杨希. 急性呼吸窘迫综合征患者血清FGF21、ANGPTL4、HO-1表达及其临床意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 227-229.
[8] 王蕤, 乔晞. 重症监护室发生急性肾损伤的危险因素[J]. 中华肾病研究电子杂志, 2023, 12(02): 93-96.
[9] 陈蕊, 杨洪娜, 方巍, 李鑫鑫, 李甜甜, 于孝义, 王艳雪, 李文玉. 血清与支气管肺泡灌洗液中细胞因子水平与肺内外ARDS的相关性研究[J]. 中华重症医学电子杂志, 2023, 09(03): 251-258.
[10] 吴梅清, 林瑾, 段美丽, 薛晓艳. 高密度脂蛋白水平对脓毒症相关的ARDS发生的影响[J]. 中华重症医学电子杂志, 2023, 09(02): 191-197.
[11] 夏金根, 胡诗雨. 体外二氧化碳清除技术的重症应用场景[J]. 中华重症医学电子杂志, 2023, 09(01): 40-45.
[12] 尹承芬, 徐磊. 再议俯卧位通气的时机[J]. 中华重症医学电子杂志, 2023, 09(01): 9-13.
[13] 陈栋玉, 潘纯, 杨毅. ARDS患者自主呼吸努力评估方法的研究进展[J]. 中华重症医学电子杂志, 2023, 09(01): 84-88.
[14] 刘平娟, 罗科城, 吴家茵, 廖康, 胡雯雯, 陈怡丽. 神经内科重症监护室患者肠道耐碳青霉烯类肠杆菌目细菌主动筛查研究[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 235-240.
[15] 李永凯, 吐尔洪·吐尔逊, 杨建中. 开颅术后患者大脑中动脉的经颅多普勒超声测量值与意识评分、血生化指标的相关性[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 221-226.
阅读次数
全文


摘要